WHEREVER radiology is practised it needs to be linked with a greater quota of research activity, particularly in the field of clinical investigation, than at present exists.
As one of the younger branches of medicine concerned with a rapidly developing art radiology need have no fears of comparison with other branches of medicine, as far as original work is concerned. Yet even so, the sciences of both radiodiagnosis and radiotherapy are already getting somewhat stabilized and have left their early highly experimental beginnings behind them. We must now see to it that our ideas and procedures are kept constantly under review. The mechanism of such critical surveillance is research. In so far as my own field of work is radiotherapy f naturally orientate what f have to say to radiotherapeutic problems. I am very sure, however, that the same principles could be applied to radiodiagnosis.
By research is meant planned investigation based on a critical attitude to present conceptions of diagnosis, or treatment, and applied to determining the true scope and most effective application of new knowledge, or to arriving at measurement of causes or effects.
In the ordinary way to do research of substantial value a man must be able, and be enabled, to give at least half his time to that aspect of his activities. Moreover, by the very nature of research that contribution will be confined to cultivation of one tiny corner of his specialty. Because of this there is much to be gained from the stimulus of having some ordinary clinical work running concurrently. Nor is this stimulus only one way; the discipline of research reflects back into and illuminates his routine clinical work.
Whole-time research work is very largely for the worker on fundamental radiobiological problems where the techniques and approach necessarily differ from those of clinical radiotherapy and where both experience and aptitude may not be suited to the clinical arena. Even there, however, there are many who would gain by not being too remote from the patient, and by being given opportunity and responsibility for a quota of clinical work. Where training or aptitude makes this undesirable, the other solution is that clinical worker and research worker have ample opportunity to intermingle.
There are many types of research. In the first place there is true laboratory research, basic or fundamental. It is concerned with illumination of the fundamental processes on which a particular branch of medicine has been built. In our case its task is to provide us with a clearer picture of the intimate reaction between radiation and living tissue. Its domain stretches from the study of the elementary initial effect of radiation on water as the universal substrate. Then through the complexities of action on proteins, nucleic acids and other cell components. From this we reach the special problems of whole tissues and organs and lastly there are the effects on whole organisms in which the complexity of the problems become more and more baffling. Very much more of this pattern of research could profitably be done. But it does call for collaboration of workers in a variety of fields and for team work. It necessitates, therefore, some kind of organized unit with considerable facilities. This basic research is Dot only a source of inspiration but is also a rich medium for the clinical investigator. Yet we must realize that this is not the only source of research material and that much can be done in the clinical field itself. Indeed it is stimulating to reflect how our present-day practice still depends not so much on academic principles discovered in the laboratories, as on accumulated empiric knowledge acquired by the old, slow, and in some ways clumsy and inefficient methods of trial and error-plus clinical intuition.
Secondly, there is research concerned with developing the instruments or processes we employ, or concerned with improving the methods by which we apply this armamentarium. Though vitally important to therapy and, in so far as we all love playing with gadgets, vitally interesting to therapists, for the most part we, as clinicians, are not in a position to make major contributions in this field. This is the home ground for our colleague the Physicist. The key work is done by him, our own contributions being mainly support and encouragement, and occasionally taking some of the credit! The medico-biological and the medical field are ours-wide open and waiting to be cultivated by us. In this field of instrumentation and pure technique we are only learning how to do better that which we are already doing-not something new and different. For instance, in the modern trend towards increasing accuracy in small volume therapy, as in beam direction, or as in the use of higher and higher voltage for its physical superiority, we can overcome the limited sensitivity of some types of tumour by reducing volume irradiated safely. Yet thereby we come no nearer the more crucial problem of altering inherent radiosensitivity.
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We accept that as it is and then, technically, make the best of the situation so presented. We all dream of improving results in that present-day scourge-lung cancer. With megavolt therapy we might with luck get as much as a 50% improvement. To expect more than that is pure fantasy.
But what does this really mean-the present 3 % to 4 % at 5 years raised to some 6 %, important to the 2 % affected but not a spectacular advance. Innate volume of tumour when first diagnosed still defeats us. But with some method of changing radiosensitivity-drugs, time factors, sensitizerswe might make this cancer curable in larger volumes and then we would lift it into the mouth, skin, cervix class at 30 %-40 %-and lift these latter to spectacular figures.
So thirdly there is clinical research, our task and one which merits closer examination. Much more should, and could, be done with profit and in more places.
There are many ways in which investigative work can be done at clinical levels which is still true planned research and not merely inspired natural improvement of method and idea. I propose to analyse two of them.
One is individual study of patients and of treatment with a degree of completeness and exactness such that the total man-power per patient is far in excess of that ordinarily expended in purely utilitarian work. But mere amount of work and profusion of tests, examinations and analyses do not of themselves make for knowledge.
Any investigation of this kind will inevitably concern one tiny little corner of the subject, and be by its nature very narrow. So it seems to me that for the most part clinical research should be carried out on a part-time basis-the half-time previously referred to. But the research half must be kept sacred and in that half at least it should be possible to work with that feeling of leisure and unlimited time which leaves no bar to the taking of infinite pains, for ultimate success depends thereon.
This meticulous study kind of research can only pay dividends when planned to definite purpose. It is all too liable to be sterile unless the investigator has clearly formulated the question or series of questions to which he is seeking an answer and is capable of building up new concepts from the data he obtains.
Let me again illustrate by example from a field with which I am for the moment concerned, the application of radio-iodine to thyroid cancer. The broad question is, of course, can we make 1131 cure thyroid cancer? But that question of itself is not nearly specific enough unless one is content with a "give some and see". We need a much more specific approach:
(1) What kind of tumours pick up iodine-and later "why"?
(2) Can any of the types of thyroid cancer which do not pick up iodine naturally be made to do so artificially, or can they not?
(3) The limiting factor in treatment may well be whole-body radiation. What is the limiting dose of radiation given this way and how can it be measured?
(4) How homogeneously is the radio-active iodine distributed in tumour when picked up? In other words is it even theoretically possible to kill the whole tumour with one shot?
(5) Can we devise tricks by which we can augment rate of pick-up and so save, relatively, wholebody radiation? and so we might go on.
One aspect of the detailed study type of research needs comment. In this technical and biochemical age it nearly always calls for considerable supporting laboratory study. This has nothing to do necessarily with basic laboratory research but is something quite different. Yet it does entail expenditure and man-power. Fortunately, it may often be met on relatively limited lines as one is not concerned with the whole gamut of laboratory activity but with merely one or two specific tests or processes related directly to the subject in hand. It seemed to me that in the United States they showed a greater capacity than we do to tie up small laboratory projects with their clinical investigations, often right on the spot in the ward side-rooms.
The critical question is, of course, who is going to do this kind of work? We are all up to the neck with what one might call utilitarian medicine, rising numbers of patients, inadequate staff, and registrar cuts. Yet research should not be lost sight of. Somehow or other time must be made for those with appropriate talents. The solution is, f know, one which needs making on a national basis for all medicine, but let us do now as much as we can with the means at our present disposal.
Then there is another type of clinical research which might prudently be well encouraged at our present stage of radiotherapeutic development and which though equally valuable is less timeconsuming-the alternative treatment experiment. It is, at least, something not needing additional man-power and to which almost everyone could contribute something, even if it does take a few years to mature.
We are all aware how much laboratory research is based on the principle of control groups of material. It is obvious that in clinical medicine the system of controls as used in laboratories can seldom be employed in its simple form, that is with a set of untreated controls as the base line of any experiment. Yet even in clinical medicine it has been done, for example in the studies on the common cold in relation to virus immunity. In the therapy of cancer this is scarcely applicable, but wherever two different treatments are available and it remains debatable which is the better, the homologous and equally informative experiment is open to us. Now this situation often exists in a clear-cut form in modem cancer therapy. Reams of print have been used to try and prove the superiority of one or other favoured method without any convincing result because the "samples" used whether in the same centre or different centres could never be regarded as genuinely comparable. Moreover, inevitably, emotional factors and prestige factors can and do creep in. I believe that much of this stalemate will persist unless we deliberately set out on a relatively large scale and on a research basis of accuracy to make direct and absolute comparisons. This entails carefully planned alternative treatment experiments with purely random allocation of cases to one or other alternative.
Here are a few examples to illustrate the scope of this kind of procedure.
(1) Where radium or X-ray are used together in the treatment of uterine cancer should X-ray precede or follow radium?
(2) Is radical X-ray treatment of breast cancer more effective at ten to fifteen weeks, as claimed by Baclesse, as compared to the three, four or five weeks which have long been employed?
(3) In the treatment of connective-tissue tumours Cade reaffirmed in his Presidential Address (1951, Proc. R. Soc. Med., 44, 19) his belief that pre-operative X-ray treatment is of real value. How easily susceptible to proof by alternative treatment test would this be?
(4) We have not yet arrived at any fiDal agreement as to the relative merits of small-field beamdirected X-ray versus radium beam therapy, in spite of Dr. Constance Wood's suggestive but not essentially conclusive study.' It is about time we knew, instead of merely arguing from insufficient evidence.
(5) So, too, I think in the treatment of polycythaemia and the leukaemias we might usefully set out to compare the older classical methods with isotope treatment not, here, in terms of survival but by contrast of hiemoglobin response and length of remissions.
A more difficult series of contrasts to launch, because it is not easy to persuade the surgeon to the complete degree of collaboration needed, is the contrast between surgery and radiotherapy in many fields. For example, there is beam-directed therapy versus laryngectomy, and once again Wertheim's operation versus radium for uterine cancer is topical.
We have been attempting in Manchester to initiate a few such projects as much with a view to evolving suitable technique as for their intrinsic value and having the future installation of megavolt therapy to plan for. Comment here on some of the principles involved may be of interest. In the first place no experiment of this kind can be conducted on man except where the known results of both methods are such that no one concerned can have any twinges of conscience about prescribing either. This is a sine qua non. The sample, therefore, must consist only of such cases as are entirely suitable for treatment by either method. A case does not go into the experimental series unless this is so. Where for a particular case any preference or bias exists, that case can be treated according to that bias, but it is not included in the experimental series. Note that this presents no problem as all the cases of a particular type seen are not necessarily included. The only essential is that once a case is put into the experiment it stays in and chance alone determines which treatment it has. For example, suppose that in a post-operative radiotherapy breast series, treated versus untreated experiment, one particular surgeon insists that his cases all get treatment. Agreed, but all his cases must be lost to the series entirely. It is important, however, not to allow too many exceptions, as clearly the more we lessen the numbers in the experimental series the longer we extend the number of years the experiment must run to provide valid conclusions.
Once a decision is firmly made that a case can ethically have either of two treatments it is "registered into the experiment". The next step becomes allocation to one or other alternative treatment group by some method of purely random or chance selection. At first sight this seems simple but in reality it is a process the technique of which will repay study and trial of a variety of methods. Our own earliest experiment of this type was an attempt at assessment of the risks of squamous-cell biopsy. Then we attempted to provide a pairing of as nearly identical cases as possible. This seemed to the ordinary person entirely logical, but the statisticians say that such artificial stratification is not sound. We are now advised that the ideal is to provide purely random allocation of every case regardless of its individual characteristics. On the basis of statistical theory it is possible to say when such a contrast series is large enough to be considered as a reasonable sample. This indeed can be checked by comparing the distribution of some neutral factors such as age, stage, sex, or the like, to show that these factors have, in fact, sufficiently equalized within the random method of allocation. The method of randomization is itself of interest and worth thought to ensure that the experiment is to be free of unexpected bias. The classical tossing of a coin would do very nicely except that the therapist would clearly have to retire out of sight for the operation, that the result is open to errors of recording and also that it is aesthetically clumsy.
There are, however, alternative methods of achieving the same end. A card can be drawn from a pack of cards marked "Yes" or "No" and indiscriminately shuffled. Then the patient's name and number are immediately entered on the card. 
896
Another method and one which I think might provide scope for ingenuity is to use some characteristic of the patient himself which varies in the ratio 1: 1 or approximately so, and which cannot have any bearing on the result of treatment. For example we might use the date of birth-Even or Odd-or the final digit of the patient's hospital registration number.
Latterly we have worked a group of experiments on the basis of the patient's date of birth. It has the advantages that it is not open to subconscious cheating, and, being permanent, it is open to subsequent check.
I have gone into this alternative treatment story at some length because I believe that this ought to be made the basis for much of the developmental work of the next five to ten years in radiotherapy. Indeed, I am going to suggest it as the only satisfactory approach to some of our impending studies. Many centres in this country are getting, or have got, megavolt units of various types. There is going to be quite a crop of isotope variants of radium, and chemotherapy already provides alternatives to radiotherapy in the palliative fields. Particularly where expensive apparatus is concerned it is essential not only to find the scope of the new instrument but, thereafter, to measure its value objectively in absolute terms by scrupulously devised and honestly carried out alternative treatment tests. The new equipment would be matched with its appropriate technique against the best of presentday classical standard therapy.
An experiment of this kind is clearly easier to do in larger centres but, because of its very simplicity, it would also lend itself admirably to collaborative work by groups of smaller units.
In the fields of radiotherapy to which research of an essentially biological and medical type could profitably be applied, I shall select three themes by way of examples from a legion of possibilities.
The first is study of the "optimum" dose, using the word "dose" in the now accepted sense of "dose in time". Radiotherapy has made great strides in the last ten years in this country. Don't let us be too modest about taking the credit due to British radiotherapy. Yet reflection shows that what we have in the main done is to learn with something approaching accuracy what doses we were giving and then how to give accurately and homogeneously any predetermined dose. But if we examine critically the grounds on which we decide the actual dose to use in given conditions we will be surprised at the continuing empiricism of much of our current practice. Yet it is reasonable to presume that for any particular condition there is always an optimum dose which would yield the maximum chance of success and that it might often be found unexpectedly different from the one we actually employ. I believe that the criteria on which that optimum dose depends could, despite the obvious difficulties, be subject to scientific study and possibly measurement. To achieve it we must ask ourselves the right questions and set about analysis of this vital factor systematically, and not by depending on mere intuition. It needs to be done not only for each disease but almost for each stage of the cancers we treat. Much ingenuity is needed to collect and present relevant data in such a way that valid deductions can be drawn. But with luck we might make thereby comparable advance in the next ten years to that obtained through evolution of dosage accuracy -in the last ten.
A second subject which constantly intrigues me is the still unexplained phenomenon of the nature of radiosensitivity with its relation to volume irradiated. Think how therapy would alter its complexion could someone devise a valid pre-treatment index of tumour sensitivity, not merely for the tumour species but for the particular individual tumour in question.
Another aspect of this same theme of resistance and sensitivity captures the imagination when we consider the dividends which would accrue from discovery of any means-clinically applicableto alter relative sensitivity. Nor need this be in any big way; even a modest 5% or 10% improvement would make an enormous difference to the size of the squamous carcinoma which we could expect to cure.
Then lastly there are isotopes to be studied. Everybody is doing it, and in every broadcast on radiotherapy by the proverbial anonymous specialist we assure the public that that is our great new hope. But let us keep our own ideas on the subject clear and avoid mere indiscriminate and purely empirical use on a miscellaneous group of cancers, hoping, Micawber-like, that something will turn up.
There cannot now be the least doubt that the application of radioactive tracers will usher in for all medicine an era as important as was the discovery of the microscope to our predecessors. Radioisotopes are research tools capable of immense exploitation but at the tracer level they must be regarded as tools, not as projects by themselves.
Along with the other branches of medicine we will use them, with the help of the chemist and the physicist. One problem is the take-up by cancer cells of labelled substances in the exploration of their abnormal physiology.
But if this be done with ingenuity we as radiotherapists may have additional reward by the discovery of a means to destroy certain cancers-by selective absorption of radio-active substances as with thyroid cancers and the leukaemias.
These are then three different examples of real medical research. The scope is almost unlimited and let us not be discouraged by the fact that these things are difficult, often disappointing, and OCT.-RADIOL. 2 unfortunately never spectacular in the eyes of the public. Yet the dividends from an inspired idea, successfully explored, might be enormous in terms of increased cure rate.
One is tempted to contrast this again with the technical streamlining of our methods of therapy, including in this category the evolution of megavolt units. The very fact that they are obviously spectacular may generate a mega-mirage in our own and the public mind-a temptation to be resisted.
What matters is just how and why radiation of any kind, however delivered, acts on tumour and tumour host. That is our proper field of research.
Enough of radiotherapy. Radiodiagnosis should offer equal scope. What is true in our limited sphere of radiology is equally true for all branches of medicine. Far too little research, and especially clinical research, is linked with the present-day practice of medicine in Britain:
Annual expenditure in the National Health Service: £355,000,000. Annual total budget of Medical Research Council, including capital expenditure: £1 9 million.
Ratio just over 05 Y%.
I know that there is considerable additional research being done under the N.H.S. in professorial units of teaching hospitals and in other ways but I doubt whether the sum of all such would double the M.R.C. figure. Even if we assume it does-I % is not an adequate fraction to give medical research its due place in the scheme of things.
Research is to medicine what operational research was to military planning in the last war, or to use another comparison, what modernization of plant and machinery is to present-day industry. One can hardly conceive of too much being done.
What are the main obstructions?
First there is the attitude that research is, in essence, but a frill or luxury, and not really vital to the structure of medicine. It is something, therefore, which tends to get cut first in the now chronic economy atmosphere.
The other obstruction is that research workers remain by tradition the financial Cinderellas of medicine. Yet research talent is rare and ought to be encouraged as something precious, and should command special rewards. Yet in practice great improvements would be made were it even rewarded on an equal basis with clinical medicine, not only in relation to what is offered to younger men but in terms of future prospects and of security. At present the attractions of the registrar-consultant ladder so outweigh what a research career seems to offer, that research talent is being strangled at birth by economic sanctions. And then people turn round and say "We'd like to get some research going but one cannot find any good men". It is all very short-sighted for in research, more than in any other sphere, the man is the key to success: "The real-discoverer is rare in all classes and it must be the object of civilized communities to find him and foster his activities. Though generally the more able the investigator the less his demands on life's amenities, the scientific genius when found must not be expected to use all his time and energy fending for a living."-(MELLANBY.) "In view of the rarity with which the abilities requisite for a fine research worker are joined in any man, the search for such persons should be deliberate yet eager, the training facilities catholic and discriminating, and our support loyal and reverent before the opportunity to be shown new truth."-(GREGG.) You may well ask, what has this to do with us? These changes in outlook and in custom have to start somewhere. Radiology has already acted a-a pacemaker for medicine in a number of fields, for example in the development of and a respect for medical statistics, and in the encouragement of adequate centralization for appropriate specialties.
In this field, too, example may teach better than precept so I put it to you that active energetic development of our responsibilities for research is a clamant need of to-day.
